SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-006132
Filing Date
2017-08-07
Accepted
2017-08-07 16:55:31
Documents
63
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20170630x10q.htm 10-Q 992586
2 EX-10.1 idra-20170630ex101cbb3c1.htm EX-10.1 280335
3 EX-31.1 idra-20170630ex311afccb8.htm EX-31.1 14220
4 EX-31.2 idra-20170630ex312887ed6.htm EX-31.2 14230
5 EX-32.1 idra-20170630ex3212eda32.htm EX-32.1 6706
6 EX-32.2 idra-20170630ex32245bf46.htm EX-32.2 6546
  Complete submission text file 0001558370-17-006132.txt   4202088

Data Files

Seq Description Document Type Size
7 EX-101.INS idra-20170630.xml EX-101.INS 826172
8 EX-101.SCH idra-20170630.xsd EX-101.SCH 33724
9 EX-101.CAL idra-20170630_cal.xml EX-101.CAL 43001
10 EX-101.DEF idra-20170630_def.xml EX-101.DEF 86369
11 EX-101.LAB idra-20170630_lab.xml EX-101.LAB 237310
12 EX-101.PRE idra-20170630_pre.xml EX-101.PRE 189343
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 171012174
SIC: 2836 Biological Products, (No Diagnostic Substances)